tiprankstipranks
Trending News
More News >
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market

Sunshine Biopharma (SBFM) Ratios

Compare
424 Followers

Sunshine Biopharma Ratios

SBFM's free cash flow for Q3 2025 was $0.33. For the 2025 fiscal year, SBFM's free cash flow was decreased by $ and operating cash flow was $-0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Mar 24Mar 23Dec 21
Liquidity Ratios
Current Ratio
4.20 4.11 4.48 3.94 24.07
Quick Ratio
2.09 2.33 3.45 3.47 22.91
Cash Ratio
1.40 1.53 2.93 3.15 22.42
Solvency Ratio
-0.78 -0.70 -0.71 -3.37 -6.24
Operating Cash Flow Ratio
-1.07 -1.98 -1.58 -0.76 -20.05
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 -42.66 0.00
Net Current Asset Value
$ 20.68M$ 18.91M$ 18.75M$ 19.39M$ 204.60K
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.03 0.02 0.03 0.86
Debt-to-Equity Ratio
0.04 0.04 0.03 0.04 8.98
Debt-to-Capital Ratio
0.03 0.04 0.03 0.03 0.90
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.90
Financial Leverage Ratio
1.30 1.30 1.29 1.37 10.41
Debt Service Coverage Ratio
-666.53 -560.63 -30.73 -164.25 -36.78
Interest Coverage Ratio
-759.21 -662.41 -34.85 -685.10 -7.42
Debt to Market Cap
0.00 0.00 0.00 0.01 0.25
Interest Debt Per Share
0.19 1.37 65.35 106.02 1.71K
Net Debt to EBITDA
1.36 1.69 4.09 0.80 0.01
Profitability Margins
Gross Profit Margin
33.01%30.60%34.61%39.05%48.42%
EBIT Margin
-17.41%-15.37%-16.49%-609.11%-5300.62%
EBITDA Margin
-16.61%-14.78%-15.87%-608.54%-5294.93%
Operating Profit Margin
-17.35%-16.67%-19.86%-621.28%-1068.18%
Pretax Profit Margin
-17.44%-15.40%-17.06%-610.01%-5444.21%
Net Profit Margin
-16.06%-14.72%-18.70%-615.37%-5444.21%
Continuous Operations Profit Margin
-16.06%-14.72%-18.70%-615.37%-5444.21%
Net Income Per EBT
92.08%95.62%109.61%100.88%100.00%
EBT Per EBIT
100.51%92.38%85.91%98.19%509.67%
Return on Assets (ROA)
-19.03%-16.80%-16.48%-90.52%-564.53%
Return on Equity (ROE)
-24.95%-21.85%-21.25%-123.66%-5875.41%
Return on Capital Employed (ROCE)
-26.07%-23.97%-21.95%-119.40%-115.55%
Return on Invested Capital (ROIC)
-23.80%-22.73%-21.84%-118.75%-115.55%
Return on Tangible Assets
-20.33%-18.64%-17.40%-92.96%-564.53%
Earnings Yield
-116.06%-243.87%-68.21%-275.28%-162.91%
Efficiency Ratios
Receivables Turnover
8.98 9.02 9.44 2.27 29.29
Payables Turnover
4.07 4.37 6.09 0.95 2.74
Inventory Turnover
1.78 2.15 2.75 0.81 1.12
Fixed Asset Turnover
26.31 23.53 23.79 3.76 32.35
Asset Turnover
1.19 1.14 0.88 0.15 0.10
Working Capital Turnover Ratio
1.71 1.79 1.21 0.39 0.22
Cash Conversion Cycle
156.34 126.97 111.63 227.72 206.71
Days of Sales Outstanding
40.64 40.49 38.67 160.59 12.46
Days of Inventory Outstanding
205.30 170.08 132.87 453.31 327.27
Days of Payables Outstanding
89.59 83.59 59.90 386.19 133.02
Operating Cycle
245.94 210.56 171.53 613.91 339.73
Cash Flow Ratios
Operating Cash Flow Per Share
-1.53 -17.86 -721.34 -691.48 -1.40K
Free Cash Flow Per Share
-1.79 -21.16 -786.12 -731.67 -1.40K
CapEx Per Share
0.26 3.31 64.78 40.18 0.00
Free Cash Flow to Operating Cash Flow
1.17 1.19 1.09 1.06 1.00
Dividend Paid and CapEx Coverage Ratio
-5.89 -5.40 -11.13 -17.21 0.00
Capital Expenditure Coverage Ratio
-5.89 -5.40 -11.13 -17.21 0.00
Operating Cash Flow Coverage Ratio
-8.33 -13.16 -13.34 -6.86 -0.96
Operating Cash Flow to Sales Ratio
-0.19 -0.36 -0.36 -1.21 -8.01
Free Cash Flow Yield
-153.00%-705.48%-144.77%-57.16%-23.96%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.86 -0.41 -1.47 -0.36 -0.61
Price-to-Sales (P/S) Ratio
0.15 0.06 0.27 2.24 33.42
Price-to-Book (P/B) Ratio
0.21 0.09 0.31 0.45 36.06
Price-to-Free Cash Flow (P/FCF) Ratio
-0.65 -0.14 -0.69 -1.75 -4.17
Price-to-Operating Cash Flow Ratio
-0.72 -0.17 -0.75 -1.85 -4.17
Price-to-Earnings Growth (PEG) Ratio
-0.12 <0.01 0.02 <0.01 >-0.01
Price-to-Fair Value
0.21 0.09 0.31 0.45 36.06
Enterprise Value Multiple
0.48 1.29 2.36 0.43 -0.62
Enterprise Value
-3.01M -6.63M -9.03M -11.35M 7.49M
EV to EBITDA
0.48 1.29 2.36 0.43 -0.62
EV to Sales
-0.08 -0.19 -0.37 -2.61 32.78
EV to Free Cash Flow
0.36 0.45 0.94 2.04 -4.09
EV to Operating Cash Flow
0.42 0.53 1.03 2.16 -4.09
Tangible Book Value Per Share
4.77 29.19 1.62K 2.75K 162.07
Shareholders’ Equity Per Share
5.20 33.49 1.74K 2.85K 162.07
Tax and Other Ratios
Effective Tax Rate
0.08 0.04 -0.10 >-0.01 0.00
Revenue Per Share
8.02 49.70 1.98K 572.60 174.91
Net Income Per Share
-1.29 -7.32 -370.41 -3.52K -9.52K
Tax Burden
0.92 0.96 1.10 1.01 1.00
Interest Burden
1.00 1.00 1.03 1.00 1.03
Research & Development to Revenue
>-0.01 0.03 0.08 0.19 2.94
SG&A to Revenue
0.39 0.40 0.42 2.05 8.17
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 4.02
Income Quality
1.19 2.44 1.95 0.20 0.15
Currency in USD